FOI release

VMD FOI requests received between 1 January and 30 June 2019

Published 28 November 2019

1. Requests about our information and communications technology (ICT) arrangements

ATI reference number Subject
ATI0564 Software applications
ATI0570 Information on Local Area Network
ATI0571 Information on IT software contracts
ATI0573 Information on Telephone and network
ATI0577 Procurement of IT services
ATI0578 Information on Procurement of Telecoms and IT Hardware and Services for VPC
ATI0583 Information about the organisation’s ICT contract(s) for Server Hardware Maintenance, Server Virtualisation Licenses and Maintenance and Storage Area Network (SAN) Maintenance/Support
ATI0584 Details of contract information relating to the following corporate software/enterprise
ATI0593 Information on the internal plans and strategy documents around ICT

2. Requests for information about certain veterinary medicinal products

ATI reference number Subject
ATI0553 VM 11543/4001 Protect Oral Suspension for New Born Calves - request for PUAR
ATI0567 Information on the decision by VMD to make Leptospira a core vaccine
ATI0569 Information on the environmental fate and effects of the active substance oxytetracycline
ATI0572 Information on efficacy studies for the veterinary medicinal product Ataxxa
ATI0586 Information on how many SICs for Milteforan or Glucantime have been applied for treatment of UK dogs
ATI0588 Request for the number of Marketing Authorisations approved by the VMD that contain Dimethylformamide in the last 5 years
ATI0589 Information on the amount of Bronopol that has been imported to the UK since the beginning of 2018
ATI0590 Details of the total kg of the active ingredient formalin that has been imported to the UK since the beginning of 2015
ATI0595 Information on the annual figures for Special Import Certificates for Milteforan & Glucantime
ATI0597 Information on the assessment of the import of Bronopol from Chile
ATI0602 Information relating to group litigation on organophosphorus sheep dip
ATI0604 Details of all products imported under the Special Import Scheme in the last 12 months

3. Requests for Pharmacovigilance information

ATI reference number Subject
ATI0565 Details of adverse events for a number of products for use in dogs
ATI0566 Pharmacovigilance data for various products authorised for use in dogs
ATI0568 Information on data and usage figures for products containing zinc oxide for use in pigs
ATI0579 Details of a pharmacovigilance report submitted by a Marketing Authorisation Holder
ATI0585 Details of pharmacovigilance data for Footvax in the last 5 years
ATI0587 Sales figures for products containing Imidacloprid and fipronil for 2018
ATI0591 Request for a report for an adverse event for the use of Convenia
ATI0594 Information on Sales Data for Zinc Oxide
ATI0596 Information on pharmacovigilance reports for Nobivac Lepto 4 vaccine
ATI0599 Information on pharmavogilance for the use of Convenia
ATI0600 Details of the number of reported Adverse reactions to canine Lepto vaccines, since 2012

4. Requests for information relating to the work of our Antimicrobial Resistance Team

ATI reference number Subject
ATI0592 Full details (description of the presentation, findings presented etc) of the University of Nottingham / APHA presentation at the DARC Committee Meeting held on the 21st Feb 2018 relating to research into farm slurry / waste and antibiotic resistance / residues

5. Requests for information relating to the work of our Enforcement Team

ATI reference number Subject
ATI0574 Details of correspondence relating to an enforcement case
ATI0575 Correspondence on an enforcement case
ATI0576 Communication on an enforcement case
ATI0580 How many unauthorised product complaints have been received in the last five years?
ATI0581 How many unauthorised product complaints were about products designed for the equine market
ATI0582 How many individual firms did you have complaints about in the last 5 years?
ATI0598 Information on the use of medicated grit